<DOC>
	<DOCNO>NCT01294384</DOCNO>
	<brief_summary>This study investigate safety , efficacy acceptability two new eye drop formulation compare Refresh Tears® patient dry eye disease .</brief_summary>
	<brief_title>Safety Efficacy Study New Eye Drop Formulations With Refresh Tears® Patients With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Current use artificial tear product least twice daily least 3 month , average Ability/agreement continue wear exist spectacle correction ( glass ) study Anticipated contact lens wear study contact lens use within 6 month Active ocular infection allergy Use topical ophthalmic medication ( eg , topical ophthalmic steroid , glaucoma drop ) within 2 week Use topical cyclosporine product within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>